Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Update

Share on StockTwits

Henry Schein, Inc. (NASDAQ:HSIC) was the target of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 8,630,000 shares, a drop of 10.2% from the August 31st total of 9,610,000 shares. Based on an average trading volume of 1,330,000 shares, the days-to-cover ratio is presently 6.5 days. Currently, 6.1% of the shares of the company are sold short.

In related news, EVP Gerald A. Benjamin sold 14,430 shares of the firm’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $68.08, for a total transaction of $982,394.40. Following the transaction, the executive vice president now directly owns 114,189 shares of the company’s stock, valued at $7,773,987.12. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.05% of the stock is currently owned by company insiders.

Large investors have recently bought and sold shares of the stock. Handelsbanken Fonder AB acquired a new stake in Henry Schein during the 2nd quarter worth approximately $2,226,000. Russell Investments Group Ltd. boosted its position in Henry Schein by 214.2% during the 2nd quarter. Russell Investments Group Ltd. now owns 403,004 shares of the company’s stock worth $23,506,000 after buying an additional 274,727 shares during the period. Wellington Management Group LLP boosted its position in Henry Schein by 92.3% during the 1st quarter. Wellington Management Group LLP now owns 59,483 shares of the company’s stock worth $3,005,000 after buying an additional 28,548 shares during the period. Vident Investment Advisory LLC boosted its position in Henry Schein by 4.0% during the 2nd quarter. Vident Investment Advisory LLC now owns 51,665 shares of the company’s stock worth $3,017,000 after buying an additional 1,977 shares during the period. Finally, Pacer Advisors Inc. acquired a new stake in Henry Schein during the 2nd quarter worth approximately $1,225,000. Institutional investors and hedge funds own 99.97% of the company’s stock.

Several equities analysts have commented on HSIC shares. Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating and set a $71.00 target price on the stock in a report on Monday, July 20th. BidaskClub lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Friday, September 25th. TheStreet lowered shares of Henry Schein from a “b” rating to a “c+” rating in a report on Tuesday, August 4th. Finally, ValuEngine lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Friday, August 7th. Five analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. Henry Schein presently has an average rating of “Hold” and an average price target of $64.33.

NASDAQ:HSIC traded up $0.05 during mid-day trading on Friday, hitting $57.97. 1,245,658 shares of the company’s stock were exchanged, compared to its average volume of 1,596,734. The company has a 50 day simple moving average of $63.79 and a 200-day simple moving average of $59.08. The company has a current ratio of 1.48, a quick ratio of 0.87 and a debt-to-equity ratio of 0.14. Henry Schein has a fifty-two week low of $41.85 and a fifty-two week high of $73.99. The firm has a market capitalization of $8.28 billion, a P/E ratio of 14.42, a PEG ratio of 4.00 and a beta of 0.97.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading: Overbought

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply